What is the primary objective of GMP?

The primary objective of GMP is to ensure products are consistently produced and controlled to meet predefined quality standards, preventing contamination, mix-ups, mislabeling, and variability through preventive controls rather than end-product testing alone. This encompasses the “5 Ps”—People, Products, Procedures, Processes, and Premises—spanning raw materials receipt to distribution, as codified in FDA 21 CFR Parts 210/211 and EU EudraLex Volume 4.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP guidelines. This includes contract manufacturers (CMOs), suppliers of starting materials, and entities exporting to regulated markets; the sponsor remains accountable for outsourced activities via quality agreements.

Does GMP require an external audit or third-party certification?

GMP does not universally mandate third-party certification but requires regular regulatory inspections by authorities like FDA or EMA, with internal audits and self-inspections as core requirements. EU GMP emphasizes PIC/S-aligned inspections; WHO GMP supports certification for procurement, but legal enforcement relies on unannounced audits verifying Quality Control Unit independence per 21 CFR §211.22.

How often should an assessment for GMP be performed?

GMP assessments, including internal audits and self-inspections, must be conducted at planned intervals with risk-based frequency, typically annually for full programs and more often for high-risk areas. FDA expects ongoing monitoring via CAPA, change control, and Product Quality Reviews (annual per 21 CFR §211.180(e)); EU GMP mandates management review and trending.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP triggers regulatory actions including Form 483 observations, Warning Letters, import alerts, product seizures, recalls, fines up to $50,000 per day (FDA), manufacturing halts, and potential criminal liability. Historical cases like Elixir Sulfanilamide (1937, 100+ deaths) underscore risks; modern enforcement includes consent decrees and market exclusion.

Can GMP be mapped to other international frameworks?

Yes, GMP aligns closely with ICH Q7 (API GMP), ICH Q9 (QRM), and ICH Q10 (PQS), enabling mapping across FDA, EU, and WHO regimes via PIC/S and MRAs. Core pillars—independent quality oversight, validation, documentation—converge, though EU Annexes (e.g., Annex 1 sterile products, applicable since 25 Aug 2024) add specificity.

What is the first step to begin implementing GMP?

The first step to implement GMP is conducting a comprehensive gap analysis against applicable regulations (e.g., 21 CFR Part 211, EU GMP Chapters), followed by developing a Validation Master Plan (VMP). This identifies deficiencies in the Pharmaceutical Quality System, prioritizes risks via QRM, and establishes remediation roadmaps with executive sponsorship.

What is the primary objective of ISO 14064?

ISO 14064 provides requirements and guidance for quantifying, reporting, and verifying greenhouse gas (GHG) emissions and removals. The standard family comprises three parts: ISO 14064-1:2018 for organizational-level inventories, ISO 14064-2:2019 for project-level reductions/removals, and ISO 14064-3:2019 for validation/verification. It enforces five principles—relevance, completeness, consistency, transparency, accuracy—to ensure credible, comparable GHG assertions for organizations, projects, and stakeholders.

Who is legally or professionally required to comply with ISO 14064?

No organization is universally legally required to comply with ISO 14064, as it is a voluntary international standard. Professionally, it applies to organizations (corporates, governments, NGOs), project developers (e.g., renewable energy, CCS), and verifiers needing credible GHG inventories for regulatory readiness (e.g., EU CSRD, California SB-253), investor disclosures, carbon markets, or supply-chain demands. Use is driven by market and stakeholder expectations for verifiable data.

Does ISO 14064 require an external audit or third-party certification?

ISO 14064 does not mandate external audit or third-party certification. Parts 1 and 2 encourage but do not require independent validation/verification under ISO 14064-3:2019, which specifies risk-based assurance (limited or reasonable levels). In practice, third-party statements from ISO 14065:2020-compliant bodies enhance credibility for emissions trading, green finance, and disclosures, though organizations may self-declare.

How often should an assessment for ISO 14064 be performed?

ISO 14064 requires annual GHG inventory assessments aligned to the organization's reporting period. Organizational inventories (Part 1) must cover a defined period (typically calendar/fiscal year) with base-year consistency and recalculations for structural changes. Project assessments (Part 2) follow monitoring plans, often periodic. Verification (Part 3) frequency depends on stakeholder needs, commonly annually for ongoing reporting.

What are the consequences of non-compliance with ISO 14064?

Non-compliance with ISO 14064 carries no direct penalties, as it is voluntary. Indirect consequences include rejected GHG claims in carbon markets, failed regulatory disclosures (e.g., EU CSRD fines), investor skepticism, greenwashing litigation risks, and exclusion from green finance/procurement. Poor inventories undermine decarbonization strategies and expose organizations to reputational damage from unverifiable assertions.

An ISO 14064 be mapped to other international frameworks?

Yes, ISO 14064 aligns closely with the GHG Protocol Corporate Standard's principles and scopes. Its five principles mirror GHG Protocol requirements, enabling interoperability for Scopes 1-3 inventories. Part 1 supports corporate reporting; Part 2 project baselines/additionality; Part 3 assurance maps to ISAE 3000/3410. It integrates with ISO 14001 EMS via PDCA for sustained compliance.

What is the first step to begin implementing ISO 14064?

The first step is defining organizational and operational boundaries. Select consolidation approach (equity share, operational/financial control) and classify emissions into Scopes 1-3 per ISO 14064-1. Document base year, reporting period, and relevance criteria to ensure relevance and completeness, forming the foundation for data collection, quantification, and assurance.

Standards Comparison

GMP vs ISO 14064

GMP

Mandatory

1963

Regulatory standards for pharmaceutical manufacturing quality control

ISO 14064

Voluntary

2018

International standard for GHG quantification, reporting, and verification.

Quick Verdict

GMP ensures manufacturing quality for pharma and life sciences via enforced controls, while ISO 14064 standardizes GHG emissions accounting across industries. Companies adopt GMP for regulatory compliance and safety; ISO 14064 for credible sustainability reporting and stakeholder trust.

Manufacturing Quality

GMP

Good Manufacturing Practices (GMP/cGMP)

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Preventive controls embedded in processes and facilities
Independent quality unit for batch release authority
Risk-based quality management (QRM) proportionality
Comprehensive documentation ensuring full traceability
Validated processes and equipment qualification lifecycle

Greenhouse Gas Accounting

ISO 14064

ISO 14064 GHG quantification and reporting standards

Cost

€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Three-part modular framework for GHG inventories, projects, assurance
Five principles: relevance, completeness, consistency, transparency, accuracy
Scopes 1-3 classification with organizational boundaries
Risk-based validation/verification processes (ISO 14064-3)
Baseline scenarios and additionality for project reductions

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

GMP Details

What It Is

Good Manufacturing Practices (GMP/cGMP) are enforceable regulatory frameworks, such as FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP, establishing minimum standards for manufacturing controls. They ensure products like pharmaceuticals and biologics are consistently produced to quality specifications through preventive, risk-based systems spanning people, premises, processes, and documentation, prioritizing design-in quality over end-testing.

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
Pharmaceutical Quality System (PQS) with QRM, CAPA, change control
Validation/qualification (IQ/OQ/PQ), documentation hierarchy, independent QA/QC oversight
Compliance via inspections, no formal certification but enforced by warnings/recalls

Why Organizations Use It

Mandated for market access, GMP mitigates contamination/mix-up risks, reduces recalls/liability, ensures supply reliability. Benefits include operational efficiency, patient protection, global harmonization via ICH Q10.

Implementation Overview

Phased risk-based approach: gap analysis, VMP, facility/equipment validation, training, audits. Applies to pharma/biologics manufacturers globally; requires ongoing inspections/self-inspections.

ISO 14064 Details

What It Is

ISO 14064 is an international standard family (ISO 14064-1:2018, -2:2019, -3:2019) providing specifications and guidance for GHG emissions quantification, reporting, and assurance. It addresses organizational inventories (Part 1), project-level reductions (Part 2), and validation/verification (Part 3) using a principle-based approach emphasizing relevance, completeness, consistency, transparency, and accuracy.

Key Components

Three modular parts covering inventories, projects, and assurance.
Core principles mirroring GHG Protocol.
Boundaries (organizational/operational), Scopes 1-3, baselines, and risk-based verification.
No fixed controls; compliance via transparent reporting and optional third-party assurance under ISO 14065.

Why Organizations Use It

Enables credible GHG disclosures for regulations (e.g., CSRD, SB-253), investors, and carbon markets.
Drives operational efficiencies, risk mitigation, and stakeholder trust.
Supports decarbonization strategies and competitive differentiation in supply chains.

Implementation Overview

Phased: governance, boundary-setting, data collection, verification.
Applies to all sizes/industries; mid-large firms typical.
Voluntary with third-party verification for credibility. (178 words)

Key Differences

Aspect	GMP	ISO 14064
Scope	Manufacturing quality controls across production lifecycle	GHG emissions quantification, reporting, verification
Industry	Pharma, biologics, devices, food, cosmetics globally	All sectors worldwide for GHG inventories/projects
Nature	Mandatory enforceable regulations with inspections	Voluntary international standards for assurance
Testing	Process validation, equipment qualification, audits	Independent validation/verification of inventories
Penalties	Warning letters, recalls, fines, shutdowns	No legal penalties, loss of credibility/certification

Scope

GMP

Manufacturing quality controls across production lifecycle

ISO 14064

GHG emissions quantification, reporting, verification

Industry

GMP

Pharma, biologics, devices, food, cosmetics globally

ISO 14064

All sectors worldwide for GHG inventories/projects

Nature

GMP

Mandatory enforceable regulations with inspections

ISO 14064

Voluntary international standards for assurance

Testing

GMP

Process validation, equipment qualification, audits

ISO 14064

Independent validation/verification of inventories

Penalties

GMP

Warning letters, recalls, fines, shutdowns

ISO 14064

No legal penalties, loss of credibility/certification

Frequently Asked Questions

Common questions about GMP and ISO 14064

GMP FAQ

ISO 14064 FAQ

You Might also be Interested in These Articles...

Top 10 NIST CSF 2.0 Myths Busted: Separating Hype from Reality for Smarter Adoption

Bust 10 NIST CSF 2.0 myths like 'only for critical infrastructure' or 'Govern replaces Identify'. Plain-English breakdowns, evidence, and fixes for flexible ris

Singapore PDPA Implementation Guide: Mastering Part 6A Breach Notification Thresholds and Timelines from Primary Statute

Master Singapore PDPA Part 6A breach notifications: statutory thresholds (risk of significant harm), 72-hour timelines, checklists, templates & frameworks. Comp

SOC 2 Audit Survival Guide: First 5 Steps to Ace Your Type 2 Audit with Infographic

Ace your SOC 2 Type 2 audit with the first 5 essential steps: evidence collection, auditor tips, red flags from SignWell's experience. Get checklists & infograp

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how GMP and ISO 14064 compare against other standards

Other GMP Comparisons

Other ISO 14064 Comparisons

What It Is

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)

Pharmaceutical Quality System (PQS) with QRM, CAPA, change control

Validation/qualification (IQ/OQ/PQ), documentation hierarchy, independent QA/QC oversight

Compliance via inspections, no formal certification but enforced by warnings/recalls

What It Is

Key Components

Three modular parts covering inventories, projects, and assurance.

Core principles mirroring GHG Protocol.

Boundaries (organizational/operational), Scopes 1-3, baselines, and risk-based verification.

No fixed controls; compliance via transparent reporting and optional third-party assurance under ISO 14065.

Aspect

GMP

ISO 14064

Scope

Manufacturing quality controls across production lifecycle

GHG emissions quantification, reporting, verification

Industry

Pharma, biologics, devices, food, cosmetics globally

All sectors worldwide for GHG inventories/projects

Nature

Mandatory enforceable regulations with inspections

Voluntary international standards for assurance

Testing

Process validation, equipment qualification, audits

Independent validation/verification of inventories

Penalties

Warning letters, recalls, fines, shutdowns

No legal penalties, loss of credibility/certification